Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Management Team
Board of Directors
Scientific Advisory Board
Business Advisory Board
Our Science
Product Pipeline
Overview
Alzheimer’s Disease
ALS
MSA
Parkinson’s Disease
Posters & Publications
News & Media
Press Releases
Events
In The News
Videos
Commentary
Podcasts
Investors
Overview
News & Events
Company Info
Financial Results
Stock Data
SEDAR
SEC Filings
Governance
Careers
Contact
SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: PMN
Analyst Coverage
SEDAR
SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-12B
10-12B/A
10-K
10-K/A
10-Q
3
4
424B3
424B5
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
SUPPL
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Date
Form
Description
PDF
Pages
02/28/22
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
4
01/28/22
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
expand_more
EX-3.1
EX-3.1(1)
EX-3.2
EX-3.2(1)
EX-4.1
EX-4.2
EX-10.1
EX-10.2
EX-10.3
EX-10.3(1)
EX-10.3(2)
EX-10.3(3)
EX-10.3(4)
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.7(1)
EX-10.7(2)
EX-10.7(3)
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.12(1)
EX-10.12(2)
EX-10.12(3)
EX-10.12(4)
EX-10.13
EX-10.14
EX-10.15
EX-10.16
EX-10.17
EX-10.18
EX-10.19
EX-10.20
EX-10.21
EX-10.22
EX-10.23
EX-10.24
EX-10.25
EX-10.26
EX-10.27
EX-10.28
EX-10.29
EX-10.30
EX-10.31
EX-10.32
EX-10.33
EX-10.34
EX-10.35
EX-10.35(1)
EX-10.36
EX-10.37
EX-10.38
EX-10.39
471
09/09/21
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
03/30/21
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
11/16/20
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
7
11/20/19
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
7
01/31/19
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
05/03/18
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
09/11/17
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
08/18/17
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
arrow_back
1…
13
14
15
16
17
18
19
20
21
22
arrow_forward
Email Alerts
Contacts